Disease: Prostatic Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 AlteredExpression group LHGDN Prostate cancer and the met hepatocyte growth factor receptor. 15327888 2004
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group LHGDN Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c. 15678502 2005
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group LHGDN Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. 12883672 2004
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group CTD_human The long tail of oncogenic drivers in prostate cancer. 29610475 2018
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 AlteredExpression group BEFREE We found that CAV1, CAV2, MET and TES mRNA expression was lower in prostate tumors than in normal prostate tissues. 15252854 2004
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 AlteredExpression group LHGDN Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells. 16870139 2006